MYX 0.66% $4.60 mayne pharma group limited

Down she goes, page-4

  1. 15,774 Posts.
    lightbulb Created with Sketch. 1441
    The half yearly report is a beautiful set of numbers. I do not know about its weighting in the healthcare sector, where the behemoth CSL resides, and deservedly, but considering Maynes trajectory, this is a good thing. I have been topping up this morning.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.